Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citalopram) by Rudberg Ida, Hendset Magnhild, Uthus Linda HÃ¥rstad, Molden Espen, Refsum Helge in Therapeutic drug monitoring (2006).

[PMID: 16418702] PubMed


Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.